COX-2 levels appear to be enhanced considerably (3–4 fold as compared to control) in human endothelial cells and HCT116 colon carcinoma cells, and to a lesser extent in primary monocytes and lymphoblastoid cells (Fig. 1), but not in several breast cancer cell lines (data not shown). This evidence concerns the gene PTGS2 and breast cancer.